![Laura Francis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Francis
Directeur Général chez
SI-BONE, INC.
Fortune : 13 M $ au 31/05/2026
Profil
Laura A. Francis is Chief Executive Officer & Director at SI-BONE, Inc. since 2021, Director at Estuary Transit District, and Independent Director at Bruker Corp.
starting in 2025.
Former roles include Director at Stemina Biomarker Discovery, Inc., Independent Director at Shockwave Medical, Inc. from 2019 to 2024, Chief Financial Officer at Bruker Corp.
from 2002 to 2004, Engagement Manager at McKinsey & Co., Inc. from 1995 to 1999, Audit Manager at Coopers & Lybrand LLP from 1988 to 1993, Chief Financial Officer, Treasurer & VP-Finance at Promega Corp.
from 2004 to 2013, Chief Operating & Financial Officer at Nutra-Park, Inc. from 2001 to 2002, Chief Financial Officer at Hypercosm LLC from 1999 to 2001, and Chief Financial Officer at Auxogyn, Inc. from 2012 to 2014.
Education includes undergraduate studies at the University of Wisconsin and an MBA from Stanford University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SI-BONE, INC. 1,99 % | 18/05/2026 | 882 126 ( 1,99 % ) | 12 M $ | 31/05/2026 |
| 01/04/2026 | 4 498 ( 0 % ) | 264 887 $ | 31/05/2026 |
Postes actifs de Laura Francis
| Sociétés | Poste | Début |
|---|---|---|
| SI-BONE, INC. | Directeur Général | 20/04/2021 |
| BRUKER CORPORATION | Directeur/Membre du Conseil | 18/02/2025 |
Estuary Transit District
 Estuary Transit District Other TransportationTransportation Provides public transit services | Directeur/Membre du Conseil | - |
Anciens postes connus de Laura Francis
| Sociétés | Poste | Fin |
|---|---|---|
| SHOCKWAVE MEDICAL | Directeur/Membre du Conseil | 31/05/2024 |
Auxogyn, Inc.
 Auxogyn, Inc. BiotechnologyHealth Technology Provides novel scientific and development biotechnology services | Directeur Financier/CFO | 01/09/2014 |
Promega Corp.
 Promega Corp. BiotechnologyHealth Technology Manufactures enzymes and other products for biotechnology and molecular biology | Directeur Financier/CFO | 01/12/2013 |
| BRUKER CORPORATION | Directeur Financier/CFO | 01/09/2004 |
Nutra-Park, Inc. | Directeur Financier/CFO | 01/03/2002 |
Formation de Laura Francis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
Stemina Biomarker Discovery, Inc.
 Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes molecular biomarkers to improve drug safety and human health | Health Technology |
SI-BONE, Inc.
 SI-BONE, Inc. Medical SpecialtiesHealth Technology Operates as a sacroiliac joint medical device company | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coopers & Lybrand LLP
 Coopers & Lybrand LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Promega Corp.
Promega Corp. BiotechnologyHealth Technology Manufactures enzymes and other products for biotechnology and molecular biology | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nutra-Park, Inc. | |
Hypercosm LLC | |
Auxogyn, Inc.
Auxogyn, Inc. BiotechnologyHealth Technology Provides novel scientific and development biotechnology services | Health Technology |
Shockwave Medical, Inc.
 Shockwave Medical, Inc. Medical SpecialtiesHealth Technology Develops intravascular devices for calcified cardiovascular disease | Health Technology |
Estuary Transit District
Estuary Transit District Other TransportationTransportation Provides public transit services | Transportation |
